Sign in

Frank Moriarty

@frankmoriarty.bsky.social
554 followers 372 following 15 posts

Associate professor, researcher and pharmacist at the School of Pharmacy and Biomolecular Sciences, RCSI. Interested in pharmacoepi, deprescribing, and open research.

PostsRepliesMedia
Reposted by Frank Moriarty
CADeN | ReCAD @caden-recad.bsky.social · 22/07/2026
Clinicians have tools to identify potentially inappropriate medications (PIMs) in older adults—but what about adults under 65? A new protocol led by our researchers outlines an international modified Delphi study to build expert consensus on PIMs for adults aged 18–65 years. 🔗 tinyurl.com/kpyyverh
223
Frank Moriarty @frankmoriarty.bsky.social · 09/06/2026
Please join myself and @brianmackenna.bsky.social for a lunchtime webinar this Thursday, 11th June. We'll be talking about the current state of medicines data in Ireland and the potential it could deliver in the future. Registration details 👇
000
Reposted by Frank Moriarty
Brian @brianmackenna.bsky.social · 13/05/2026
Ireland has amongst the highest over-the-counter codeine sales internationally. Meanwhile opioid prescribing in Ireland has risen, whilst falling in England. I wrote about why the Irish health service needs to confront its opioid problem on Linkedin: www.linkedin.com/pulse/irish-... brief🧵
linkedin.com
The Irish health service needs to confront its opioid problem
Recent research shows Ireland has amongst the highest over-the-counter codeine sales internationally, and that prescriptions for painkillers, particularly opioids, have risen steadily over the last de...
136
Reposted by Frank Moriarty
DIAMOND Research Programme @diamond-derx.bsky.social · 29/04/2026
#DIAMOND's Anais Essilini presenting findings from an overview of reviews on medications associated with serotonin syndrome. Her work underscores the challenges of evidence synthesis for rare serious adverse events where reports are dominated by case reports #ICOD2026 #DIAMOND #deprescribing
072
Reposted by Frank Moriarty
DIAMOND Research Programme @diamond-derx.bsky.social · 29/04/2026
DePhaRM's Zakir Khan presenting his work on adverse drug withdrawal events reported in US & EU pharmacovigilance databases #DIAMOND #deprescribing #ICOD2026
031
Reposted by Frank Moriarty
DIAMOND Research Programme @diamond-derx.bsky.social · 29/04/2026
DePhaRM's Alex McKibben presents findings from her systematic review of international guidelines to identify patients for medication review in primary care. #ICOD2026 #DIAMOND #deprescribing
021
Reposted by Frank Moriarty
DIAMOND Research Programme @diamond-derx.bsky.social · 29/04/2026
#DIAMOND's Ryan Muddiman presenting again today with findings from a cohort study examining medication interval patterns amongst older adults in primary care #deprescribing #ICOD2026
021
Reposted by Frank Moriarty
DIAMOND Research Programme @diamond-derx.bsky.social · 29/04/2026
The morning kicking off with a plenary talk from Muhammad Mamdani on Applied AI in healthcare and the implications for #deprescribing, with #DIAMOND PI @frankmoriarty.bsky.social delivering the speaker introduction
021
Reposted by Frank Moriarty
DIAMOND Research Programme @diamond-derx.bsky.social · 28/04/2026
Another RCSI colleague, Caroline McCarthy, now moderating a Fireside Chat with Ross Upshur on "Becoming what you research" at #ICOD2026. #DIAMOND #deprescribing
021
Reposted by Frank Moriarty
DIAMOND Research Programme @diamond-derx.bsky.social · 28/04/2026
RCSI colleague and member of @frankmoriarty.bsky.social's DePhaRM group, Zakir Khan joins Ariel Green, Shin Liau, and Orla Sheehan for a panel discussion, moderated by @reeve-research.bsky.social on understanding adverse drug withdrawal events in #deprescribing. #ICOD2026 #DIAMOND
011
Reposted by Frank Moriarty
DIAMOND Research Programme @diamond-derx.bsky.social · 28/04/2026
DIAMOND's @annsinead.bsky.social joins James Sheppard and John Tazare on a panel moderated by DIAMOND's @frankmoriarty.bsky.social to explore methodological challenges in studying deprescribing with real-world data. Lots of interest in this discussion. #ICOD2026 #DIAMOND #deprescribing
131
Reposted by Frank Moriarty
DIAMOND Research Programme @diamond-derx.bsky.social · 27/04/2026
​DIAMOND collaborator Wade Thompson also on the #ICOD2026 program with a pre-conference workshop on "From preferences to practice: applying preference research to advance deprescribing" with Ariel Green & Aisling McEvoy. #ICOD2026 #DIAMOND #deprescribing
011
Reposted by Frank Moriarty
DIAMOND Research Programme @diamond-derx.bsky.social · 27/04/2026
@dremilymcd.bsky.social kicking off proceedings with the #ICOD2026 welcoming address. #ICOD2026 #DIAMOND #deprescribing
031
Reposted by Frank Moriarty
DIAMOND Research Programme @diamond-derx.bsky.social · 27/04/2026
Shout out to our RCSI colleague, Caroline McCarthy, who is taking part in a pre-conference panel on "How we prepare clinicians to deprescribe? An international perspective" #ICOD2026 #DIAMOND #deprescribing
011
Reposted by Frank Moriarty
DIAMOND Research Programme @diamond-derx.bsky.social · 27/04/2026
The #ICOD2026 networking continues with the early career researcher networking session being led by DIAMOND's @frankmoriarty.bsky.social #DIAMOND #deprescribing
011
Reposted by Frank Moriarty
DIAMOND Research Programme @diamond-derx.bsky.social · 27/04/2026
The #ICOD2026 pre-conference networking continues with the @deprescribeus.bsky.social Early Career Investigator meeting. Lovely to see UCC's Kieran Dalton as a panelist on the moderated panel on navigating your early-career path. Also feat Michelle Keller, Jinjiao Wang, moderated by Amanda Mixon
121
Reposted by Frank Moriarty
DIAMOND Research Programme @diamond-derx.bsky.social · 27/04/2026
DIAMOND's @annsinead.bsky.social & @frankmoriarty.bsky.social kick off the morning by catching up with colleagues from @deprescribeus.bsky.social at the #ICOD2026 USDeN Junior Investigator breakfast. #DIAMOND #deprescribing
021
Reposted by Frank Moriarty
Marita Hennessy @maritahennessy.bsky.social · 06/03/2026
Associations between pharmaceutical industry interactions with physicians and chronic nonmalignant pain management prescribing practices: a systematic review link.springer.com/article/10.1... Mohammed Gharbia, Lydia Iladiva, @frankmoriarty.bsky.social, Tom Fahey & @jameslarkin13.bsky.social
link.springer.com
Associations between pharmaceutical industry interactions with physicians and chronic nonmalignant pain management prescribing practices: a systematic review - Cost Effectiveness and Resource Allocati...
Cost Effectiveness and Resource Allocation - Chronic nonmalignant pain (CNMP) is commonly treated with opioids and other analgesics, yet prescribing carries risks and substantial costs. Promotional...
033
Frank Moriarty @frankmoriarty.bsky.social · 29/01/2026
Our first paper from the @diamond-derx.bsky.social research programme funded by @wellcometrust.bsky.social is out! We sought to understand how simulation studies in pharmacoepidemiology have been conducted, led by Dr Ryan Muddiman @rcsi.bsky.social
020
Reposted by Frank Moriarty
DIAMOND Research Programme @diamond-derx.bsky.social · 21/01/2026
We are pleased to share our latest publication in Pharmacoepidemiology and Drug Safety (PDS). 🔗https://doi.org/10.1002/pds.70329​ We reviewed statistical simulations published in PDS, the flagship #pharmacoepidemiology journal, between 2017 and 2024 and focused on implementation & reporting. 1/4
121
Frank Moriarty @frankmoriarty.bsky.social · 27/06/2025
Just ten days left to apply for this Research Fellow position, focused on pharmacoepidemiology and deprescribing. More information about the DIAMOND programme available at: diamond-deprescribing.eu Full job description here (deadline July 7th): my.corehr.com/pls/rcsirecr...
diamond-deprescribing.eu
Home
DIAMOND is an ambitious Wellcome-funded programme of research that aims to develop and advance novel methods for researching deprescribing by harnessing big data.
112
Reposted by Frank Moriarty
RCSI School of Population Health @rcsipophealth.bsky.social · 25/06/2025
A conference exploring how clinical research, medication safety and patient empowerment could impact national initiatives to support ageing adults took place in Dublin today, organised by @rcsipophealth.bsky.social and @tcddublin.bsky.social
121
Reposted by Frank Moriarty
DIAMOND Research Programme @diamond-derx.bsky.social · 20/06/2025
#DePhaRM group and @frankmoriarty.bsky.social were delighted to welcome Dr Justin Turner (@optimisingrxuse.bsky.social) for today’s @rcsi.bsky.social PBS seminar. He gave an inspiring look at Pharmacist-led #deprescribing in real-world care through the SaferMedsNL initiative. #ImplementationScience
261
Frank Moriarty @frankmoriarty.bsky.social · 23/06/2025
Interested in medications, data and deprescribing? We're looking for a Research Fellow to join the @diamond-derx.bsky.social team @rcsi.bsky.social! If you're an experienced researcher interested in harnessing routine healthcare data, please apply by 7 July: my.corehr.com/pls/rcsirecr...
133
Reposted by Frank Moriarty
Annals of Family Medicine @annfammed.bsky.social · 11/06/2025
This early access original research study identifies five clinically relevant prescribing cascades in a national sample of more than half a million older adults in Ireland. #FMsky#Medsky #PrimaryCare www.annfammed.org/content/earl...
152
Reposted by Frank Moriarty
James Larkin @jameslarkin13.bsky.social · 03/06/2025
On Saturday, the Irish Times published a piece I wrote asking whether Novo Nordisk should be funding children’s playgrounds. We need to ask if there are hidden costs to Novo Nordisk funding parts of our education and health systems, costs that may not be worth paying for. shorturl.at/erwpH
shorturl.at
Should the maker of Ozempic be funding children’s playgrounds in Ireland?
In 2023, Novo Nordisk was suspended by its own industry body in the UK for two years over its sponsorship of weight management courses for health professionals
078
Reposted by Frank Moriarty
DIAMOND Research Programme @diamond-derx.bsky.social · 29/05/2025
Well done to WP lead Ryan Muddiman & review co-authors: Florencia Ines Aiello Battan, John Tazare, @annaschultze.bsky.social, Teresa Perez, Li Wei, @fionaboland.bsky.social, @marywalsh14.bsky.social @frankmoriarty.bsky.social #CausalInference #Deprescribing #DIAMOND diamond-deprescribing.eu
diamond-deprescribing.eu
Home
DIAMOND is an ambitious Wellcome-funded programme of research that aims to develop and advance novel methods for researching deprescribing by harnessing big data.
012
Reposted by Frank Moriarty
DIAMOND Research Programme @diamond-derx.bsky.social · 29/05/2025
DIAMOND WP2 is exploring how simulation can support target trial emulation in deprescribing research. We recently conducted a review of simulation studies - 📢preprint now here: doi.org/10.1101/2025.... We also attended a brilliant simulation course led by Tim Morris, UCL: tinyurl.com/UCLSimTraining
doi.org
Pharmacoepidemiology simulation study practices: A methodological review
Purpose Simulation studies are used in pharmacoepidemiology for evaluating inferential methods in a controlled setting, whereby a known data-generating mechanism allows evaluation of the performance o...
142
Frank Moriarty @frankmoriarty.bsky.social · 28/05/2025
Last few days to apply for this funded PhD on deprescribing in chronic kidney disease, closes on Monday 2nd June!
022
Reposted by Frank Moriarty
James Larkin @jameslarkin13.bsky.social · 28/05/2025
Publication: We modelled the impact of post-2016 changes to prescription medicine co-payment charges and cost caps on out-of-pocket prescription expenditure Mean annual expenditure for medical card holders reduced from €117 to €55. For the DPS-group, it reduced from €719 to €555 shorturl.at/l7OAh
sciencedirect.com
Modelling the impact of changes to prescription medicine cost-sharing schemes among middle aged and older adults
To assess impacts of government changes to prescription medicine co-payments on individuals’ out-of-pocket expenditure.Participants were community-dwe…
111
Frank Moriarty @frankmoriarty.bsky.social · 16/05/2025
We're looking for a PhD scholar for a @hrbireland.bsky.social funded 4-year project focused on prescribing and deprescribing in chronic kidney disease, based at @rcsi.bsky.social. If interested in pharmacoepi/health services research, please apply (D/L 2nd June): www.rcsi.com/dublin/resea...
rcsi.com
Enhancing prescribing In chronic kidney disease in primary care (EPIC)
The overall research project aims to develop a comprehensive set of indicators to guide medicines optimisation and deprescribing in people with CKD in primary care. More ...
021
Reposted by Frank Moriarty
DIAMOND Research Programme @diamond-derx.bsky.social · 07/04/2025
Great 2nd DIAMOND Steering Group meeting today on #WorldHealthDay, bringing together diverse expertise in:  📈 Biostatistics & Data Science  🏥 Health Services Research & GP 💊 Pharmacy & Pharmacoepidemiology  🗣️ Patient & Public Involvement Details here: diamond-deprescribing.eu/team/. #HopefulFutures
143
Reposted by Frank Moriarty
Mary Walsh @marywalsh14.bsky.social · 08/04/2025
Excited to be part of this innovative programme of work @rcsi.bsky.social led by my long-time colleague @frankmoriarty.bsky.social. It has the potential to transform #bigdata research in this field, making it transparent and reproducible, informing challenging clinical decisions globally! 🌍 #DIAMOND
021
Frank Moriarty @frankmoriarty.bsky.social · 07/04/2025
We're officially launching the DIAMOND research programme today, hosted by @rcsi.bsky.social. Our research focuses on #deprescribing and #bigdata, check out our website below for more information and follow for updates 👇
041
Reposted by Frank Moriarty
CADeN | ReCAD @caden-recad.bsky.social · 19/03/2025
Planning for ICOD3 has launched! 🚀 The ICOD3 planning committee met for the 1st time to brainstorm vision & objectives for the meeting, to be held in Spring 2026 in Canada and co-hosted by CADeN & @deprescribeus.bsky.social. Stay tuned for more info: official dates and venue are coming soon! 👀
172
Frank Moriarty @frankmoriarty.bsky.social · 14/03/2025
Very pleased to launch RxTrends, a tool to visualise open data on medication prescribing in Ireland: cdrx-project.eu/rxtrends/. It was developed by Dr Ahmed Hassan Ali as part of the HRB-funded CDRx project. You can read more about the tool in the companion paper: hrbopenresearch.org/articles/8-36
hrbopenresearch.org
HRB Open Research Article: RxTrends: An R-based Shiny Application for Visualising Open Data on Prescribed Medications in Ireland.
Read the latest article version by Ahmed Hassan Ali, Michelle Flood, Ciara Kirke, Molly Mattsson, Mary E. Walsh, Emma Wallace, Derek Corrigan, Tom Fahey, Fiona Boland, Frank Moriarty, at HRB Open Rese...
141